Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-1998 | 08-1998 | 05-1998 | 02-1998 | 11-1997 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 5,490 | 6,080 | 6,350 | 6,150 | 6,955 |
| TOTAL | $5,490 | $6,080 | $6,350 | $6,150 | $6,955 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 18,430 | N/A |
| Investments And Advances | 49,290 | 58,850 | 43,260 | 46,320 | 44,752 |
| Other Non-Current Assets | 8,830 | 8,420 | 8,420 | 6,630 | 5,150 |
| TOTAL | $58,120 | $67,270 | $51,680 | $71,380 | $49,902 |
| Total Assets | $63,610 | $73,350 | $58,030 | $77,530 | $56,857 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,260 | 4,280 | 4,910 | 5,070 | 4,182 |
| Accrued Expenses | 11,560 | 10,040 | 10,080 | 9,690 | 9,612 |
| Other current liabilities | 16,530 | 16,360 | 15,620 | 16,180 | 13,834 |
| TOTAL | $35,360 | $32,660 | $31,910 | $33,680 | $28,612 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 7 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $7 |
| Total Liabilities | $35,360 | $32,660 | $31,910 | $33,680 | $28,619 |
| Shareholders' Equity | |||||
| Common Shares | 58,010 | 64,950 | 65,450 | 63,640 | 64,568 |
| Other shareholders' equity | -510 | -1,010 | -1,420 | -1,290 | -1,371 |
| TOTAL | $57,500 | $63,940 | $64,030 | $62,350 | $63,197 |
| Total Liabilities And Equity | $92,860 | $96,600 | $95,940 | $96,030 | $91,816 |